Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes.
To examine the process of liver repopulation by transplanted hepatocytes, we developed transgenic mice carrying a mouse major urinary protein-urokinase-type plasminogen activator fusion transgene. Expression of this transgene induced diffuse hepatocellular damage beginning at 3 weeks of age, and homozygous mice supported up to 97% parenchymal repopulation by healthy donor hepatocytes transplanted into the spleen. Using this transplantation model, we determined that 1) a mean of 21% of splenically injected hepatocytes engraft in liver parenchyma; 2) a mean of 6.6% of splenically injected hepatocytes (or one-third of engrafted cells) can give rise to proliferating hepatocyte foci; 3) transplanted cells in proliferating foci display an initial cell-doubling time of 28 hours, and focus growth continues through a mean of 12 cell doublings; 4) hepatocytes isolated from young and aged adult mice display similar focus repopulation kinetics; 5) the extent of repopulated parenchyma remains stable throughout the life of the recipient mouse; and 6) tetraploid and octaploid hepatocytes can support clonal proliferation.
Weglarz
T C
TC
Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Degen
J L
JL
Sandgren
E P
EP
D000375:Aging / Q000502:physiology; D000818:Animals; D002455:Cell Division; D022781:Hepatocytes / Q000166:cytology / Q000502:physiology / Q000637:transplantation*; D007267:Injections; D007700:Kinetics; D008107:Liver Diseases / Q000601:surgery*; D051379:Mice; D008822:Mice, Transgenic / Q000235:genetics; D011003:Ploidies; D011506:Proteins / Q000235:genetics; D013154:Spleen; D014568:Urokinase-Type Plasminogen Activator / Q000235:genetics
D011506:Proteins; C035737:major urinary proteins; D014568:Urokinase-Type Plasminogen Activator